Dr. Jordan Gauthier – Results from Phase 3 TRANSFORM Trial By Adam Barkay|2021-06-15T21:28:36+00:00June 15th, 2021|All, ASCO 2021|Comments Off on Dr. Jordan Gauthier – Results from Phase 3 TRANSFORM Trial Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkEmail About the Author: Adam Barkay Related Posts Prof. He Huang – Non-viral, specifically targeted CAR-T cells, achieve high safety and efficacy in B-NHL Prof. He Huang – Non-viral, specifically targeted CAR-T cells, achieve high safety and efficacy in B-NHL Prof. Mikkael Sekeres – Azacitidine plus venetoclax for myelodysplastic syndromes Prof. Mikkael Sekeres – Azacitidine plus venetoclax for myelodysplastic syndromes Dr. Adi Nagler – Single cell sequencing to chronic lymphocytic leukemia Dr. Adi Nagler – Single cell sequencing to chronic lymphocytic leukemia Prof. Meral Beksac – The recent developments in the field of bispecific T-cell engagers Prof. Meral Beksac – The recent developments in the field of bispecific T-cell engagers Prof. Selim Corbacioglu – The importance of veno-occlusive disease prophylaxis Prof. Selim Corbacioglu – The importance of veno-occlusive disease prophylaxis
